IBM is associated with an increase in terminally differentiated KLRG+ CD8+ T cells in blood and muscles, which are highly cytotoxic and release proinflammatory cytokines such as IFN-γ and TNFα (51, 52). The gene discussed is CD8A; the disease is inclusion body myositis.